Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design

被引：32

作者：

Huband, Michael D. ^{[1
]}

Ito, Akinobu ^{[2
]}

Tsuji, Masakatsu ^{[2
]}

Sader, Helio S. ^{[1
]}

Fedler, Kelley A. ^{[1
]}

Flamm, Robert K. ^{[1
]}

机构：

[1] JMI Labs, North Liberty, IA 52317 USA

[2] Shionogi & Co Ltd, Drug Discovery & Dis Res Lab, Toyonaka, Osaka, Japan

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2017年 / 88卷 / 02期

关键词：

Cefiderocol; S-649266; Quality control; M23; Siderophore cephalosporin; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; VITRO ANTIMICROBIAL ACTIVITY; SIDEROPHORE CEPHALOSPORIN; CEFTAZIDIME-AVIBACTAM; S-649266; AGENTS;

D O I：

10.1016/j.diagmicrobio.2017.03.011

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Cefiderocol (formerly S-649266) is a new catechol-substituted parenteral siderophore cephalosporin with potent in vitro antibacterial activity against Gram-negative isolates including multidrug-resistant strains. A recent study following CLSI M23-A4 quality control guidelines established cefiderocol MIC QC ranges against Escherichia coil ATCC 25922 (0.06-0.5 mu g/mL) and Pseudomonas aeruginosa ATCC 27853 (0.06-0.5 mu g/mL). (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：198 / 200

页数：3

共 17 条

[1]

[Anonymous], 2016, Clinical Practice Guideline: Postpartum Haemorrhage, P1

[2]

[Anonymous], 2014, NAT STRAT COMB ANT R

[3]

Clinical and Laboratory Standards Institute (CLSI), 2012, M07A10 CLSI, pM07, DOI DOI 10.4103/0976-237X.91790

[4]

Clinical and Laboratory Standards Institute (CLSI), 2016, M23A4 CLSI

[5]

Gould LH., 2013, MMWR, V62, P1

[6]

Ito A, 2015, 25 ECCMID

[7] Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa [J].

Ito, Akinobu ;

Nishikawa, Toru ;

Matsumoto, Shuhei ;

Yoshizawa, Hidenori ;

Sato, Takafumi ;

Nakamura, Rio ;

Tsuji, Masakatsu ;

Yamano, Yoshinori .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (12) :7396-7401

[8] In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria [J].

Ito, Akinobu ;

Kohira, Naoki ;

Bouchillon, Samuel K. ;

West, Joshua ;

Rittenhouse, Stephen ;

Sader, Helio S. ;

Rhomberg, Paul R. ;

Jones, Ronald N. ;

Yoshizawa, Hidenori ;

Nakamura, Rio ;

Tsuji, Masakatsu ;

Yamano, Yoshinori .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) :670-677

[9] Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases [J].

Ito-Horiyama, Tsukasa ;

Ishii, Yoshikazu ;

Ito, Akinobu ;

Sato, Takafumi ;

Nakamura, Rio ;

Fukuhara, Norio ;

Tsuji, Masakatsu ;

Yamano, Yoshinori ;

Yamaguchi, Keizo ;

Tateda, Kazuhiro .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) :4384-4386

[10] In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains [J].

Kohira, Naoki ;

West, Joshua ;

Ito, Akinobu ;

Ito-Horiyama, Tsukasa ;

Nakamura, Rio ;

Sato, Takafumi ;

Rittenhouse, Stephen ;

Tsuji, Masakatsu ;

Yamano, Yoshinori .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) :729-734

← 1 2 →